Pharma Giant AstraZeneca Takes China Probes
BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...
LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
The Associated Press on MSN5d
Don’t wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccinesHealth officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
News Medical on MSN4d
Public trust in COVID-19 vaccine science influences vaccine uptake in the USResearchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.
AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...
Eric Le Berrigaud, an analyst from Stifel Nicolaus, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price target remains the same with p14,100.00. Eric Le Berrigaud ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
VOV.VN - Báo điện tử VOV, tin tức thời sự về chính trị, kinh tế, đời sống, xã hội, pháp luật, thể thao, văn hóa, giải trí, ...
Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback